Dr. Milan Radovich, PhD joined Caris Life Sciences in September 2021 as Chief Precision Medicine Officer and Senior Vice President. In this role, he leads Caris’ efforts in data-driven scientific advancements in biomarkers, therapeutic recommendations, genomic medicine, target discovery and drug development.
Before joining Caris, Dr. Radovich was an associate professor at the Indiana University School of Medicine, Vice President for Oncology Genomics at Indiana University Health, and co-director of the IU Health Precision Genomics Program, a clinical program dedicated to the integration of cutting-edge genomics for the care of advanced cancer patients. His research expertise focused on the use of genomics in translational oncology, particularly on the use of genomics in clinical studies, genomically-informed drug combinations, circulating biomarkers for cancer detection, and creating novel bioinformatic pipelines for cancer genome analyses. His work has been published in many high-impact journals and presented at international oncology meetings.